Kandu Health today announced positive results from the first randomized controlled trial of its brain-computer interface (BCI ...
Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised ...
The Rapid RCT Lab has worked with 16 departments across NYU Langone and completed 47 trials, and we are currently involved in ...
The Rapid RCT Lab is a nationally-leading team conducting innovative, rapid RCTs to improve the delivery of services at the ...
The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...
A massive analysis of randomized trials suggests that most side effects listed on statin labels may not be caused by the ...
Randomized, blinded clinical study evaluating injectable autologous hair follicle secretome in patients with androgenic ...
Statin labels should be revised to reflect their safety and to hopefully spur better uptake and adherence, say experts.
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
PDE6A-associated RP, a rare form of inherited retinal disease (IRD), is characterized by nyctalopia, visual field defects, and significant loss of visual acuity (VA). The disease primarily affects the ...
A new study suggests that cognitive training may reduce dementia risk. This is the first study to examine long-term links between brain training and dementia risk. Cognitive training and healthy ...
A new randomized controlled study funded by the Crohn’s & Colitis Foundation found that time-restricted feeding—a form of intermittent fasting—significantly reduced symptomatic disease activity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results